About Squarex

We are a clinical stage pharmaceutical company developing a topical formulation of the immunomodulator squaric acid dibutyl ester for the prevention of recurrent cold sores (herpes labialis) and other infections caused by Herpes Simplex Virus 1 or Herpes Simplex Virus 2.

More than 9 Million people in the US suffer 6 or greater herpes labialis outbreaks every year with no existing medications indicated for the prevention of additional occurrences.